Literature DB >> 11782333

Anesthetic management for a patient with Jansky-Bielschowsky disease.

Yuko Yamada1, Katsushi Doi, Shinichi Sakura, Yoji Saito.   

Abstract

PURPOSE: To describe the anesthetic management of a patient with Jansky-Bielschowsky disease (JBD), the late infantile form of neuronal ceroid lipofuscinosis, characterized by dementia, severe and drug resistant grand mal, myoclonic seizures, and blindness. CLINICAL FEATURES: A 14-yr-old girl with JBD was scheduled for resection of a gingival tumour and an infected sinus in the sacral area. Her preanesthetic examination revealed extreme muscle atrophy and dementia. Grand mal, myoclonic seizures, and upper airway obstruction were frequent. Following iv induction with thiamylal, anesthesia was maintained with sevoflurane, N(2)O and O(2). Her trachea was intubated without using muscle relaxants. Muscle relaxants were not used during the operation. Apart from an intractable hypothermia, the intraoperative course was uneventful. The emergence of anesthesia was smooth, except for persisting seizures.
CONCLUSION: General anesthesia using thiamylal and sevoflurane provided satisfactory conditions during operation in a patient with JBD. Intraoperative hypothermia required particular attention.

Entities:  

Mesh:

Year:  2002        PMID: 11782333     DOI: 10.1007/BF03020423

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  3 in total

1.  Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia.

Authors:  Ning Miao; Sondra W Levin; Eva H Baker; Rafael C Caruso; Zhongjian Zhang; Andrea Gropman; Deloris Koziol; Robert Wesley; Anil B Mukherjee; Zenaide M N Quezado
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

2.  Perioperative care of a patient with neuronal ceroid lipofuscinoses.

Authors:  Hiromi Kako; David P Martin; Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2013-07

3.  Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.

Authors:  Sara E Mole; Angela Schulz; Eben Badoe; Samuel F Berkovic; Emily C de Los Reyes; Simon Dulz; Paul Gissen; Norberto Guelbert; Charles M Lourenco; Heather L Mason; Jonathan W Mink; Noreen Murphy; Miriam Nickel; Joffre E Olaya; Maurizio Scarpa; Ingrid E Scheffer; Alessandro Simonati; Nicola Specchio; Ina Von Löbbecke; Raymond Y Wang; Ruth E Williams
Journal:  Orphanet J Rare Dis       Date:  2021-04-21       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.